J.P. Morgan Private Wealth Advisors’s PDL BioPharma, Inc. PDLI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-139,113
| Closed | -$517K | – | 1501 |
|
|
2019
Q1 | $517K | Buy |
139,113
+63,614
| +84% | +$236K | ﹤0.01% | 1026 |
|
|
2018
Q4 | $219K | Sell |
75,499
-127,327
| -63% | -$369K | ﹤0.01% | 1306 |
|
|
2018
Q3 | $534K | Hold |
202,826
| – | – | ﹤0.01% | 1045 |
|
|
2018
Q2 | $474K | Buy |
202,826
+60,729
| +43% | +$142K | ﹤0.01% | 1024 |
|
|
2018
Q1 | $418K | Hold |
142,097
| – | – | ﹤0.01% | 930 |
|
|
2017
Q4 | $390K | Hold |
142,097
| – | – | ﹤0.01% | 961 |
|
|
2017
Q3 | $481K | Hold |
142,097
| – | – | ﹤0.01% | 862 |
|
|
2017
Q2 | $351K | Buy |
142,097
+71,023
| +100% | +$175K | ﹤0.01% | 955 |
|
|
2017
Q1 | $161K | Hold |
71,074
| – | – | ﹤0.01% | 1266 |
|
|
2016
Q4 | $151K | Hold |
71,074
| – | – | ﹤0.01% | 1188 |
|
|
2016
Q3 | $238K | Hold |
71,074
| – | – | ﹤0.01% | 1080 |
|
|
2016
Q2 | $223K | Buy |
+71,074
| New | +$223K | ﹤0.01% | 1112 |
|
|
2015
Q2 | – | Sell |
-39,323
| Closed | -$276K | – | 1193 |
|
|
2015
Q1 | $276K | Sell |
39,323
-129
| -0.3% | -$905 | ﹤0.01% | 921 |
|
|
2014
Q4 | $304K | Hold |
39,452
| – | – | ﹤0.01% | 868 |
|
|
2014
Q3 | $294K | Buy |
+39,452
| New | +$294K | ﹤0.01% | 851 |
|